Pages
Products
AAV8-Syn-Cre

AAV8-Syn-Cre

Cat.No. :  AAV00217Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 8 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00217Z
Description AAV serotype 8 particles contain Cre recombinase under the human synapsin promoter.
Serotype AAV Serotype 8
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

AAV is a single-stranded DNA parvovirus whose genome consists of the rep gene and the cap gene, flanked by two inverted terminal repeats (ITRs). The rep gene encodes, from a single ORF, Rep78, Rep68, Rep52 and Rep40, which aid AAV genome replication and virion assembly. The three capsid proteins (virion protein 1 (VP1), VP2, and VP3) are produced from a single cap ORF. Only 145 bp of the AAV ITRs are required for recombinant AAV (rAAV) propagation, and these ITRs induce transgene expression and play an important role in vector production and ensuring sustained cell transduction. Thus, essentially 96% of the AAV genome can be removed to allow engineering of AAV vectors for gene therapy. In fact, replacement of the rep and cap genes with an expression cassette containing a promoter, therapeutic transgene, and a poly(A) tail constitutes the essence of all AAV vectors. To date, at least 12 natural serotypes and more than 100 AAV variants have been isolated and studied as gene delivery vectors, and AAV mutants are constantly being generated from these vectors to optimize the use of AAV in gene delivery. Different AAV serotypes have different binding receptors and tissue tropisms, and multiple AAV serotypes have been used in clinical trials for patients with various diseases, including AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, and AAVrh10 (AAVrh10 was isolated from rhesus macaques (rh)), as well as some mutants, including AAV2.5, AAV Spark100, AAV.7m8, and AAVtYF.

The angiomotin (Amot)-Yes-associated protein 1 (Yap1) complex plays an important role in regulating the inhibition of cell contact, cellular polarity, and cell growth in many cell types. However, the roles of Amot and the Hippo pathway transcriptional coactivator Yap1 in the central nervous system remain unclear. Here, researchers show that Amot is a key mediator of dendritic morphogenesis in cultured hippocampal cells and Purkinje cells in the brain. The function of Amot in developing neurons depends on interaction with Yap1, which is also essential for dendritic growth and arborization in vitro. Conditional deletion of Amot and Yap1 in neurons results in reduced complexity of Purkinje cell dendritic trees, abnormal cerebellar morphology, and impaired motor coordination. These results suggest that the role of Amot and Yap1 in dendritic growth does not depend on interaction with TEA domain (TEAD) transcription factors or expression of Hippo pathway-dependent genes. Instead, Amot and Yap1 regulate dendritic development by affecting phosphorylation of S6 kinase and its target S6 ribosomal protein.

To be able to observe the morphology of individual Amot−/− Purkinje cells, the researchers intracerebrally injected newborn Amot fl/fl;STOP-Tom pups and control STOP-Tom pups with low-titer serotype 8 adeno-associated virus (AAV8) that expressed Cre under the neuron-specific synapsin 1 promoter (AAV8-Syn-Cre; Figure 1A). AAV8 has previously been shown to have high tropism for Purkinje cells, allowing cell type-specific expression of Cre and deletion of Amot in Purkinje cells. Three weeks after virus injection, animals were humanely killed, and the morphology of Purkinje cell dendritic trees was analyzed using high-power images of 100 μm sagittal sections of the cerebellum (Figure 1A and B). The researchers measured Purkinje cell dendritic tree height and width, primary and secondary branch lengths, dendritic field area and the number of dendritic branch points. All these measurements were significantly reduced in Amot−/− Purkinje cells compared with control cells, indicating impaired dendritic branching of Purkinje cells in vivo (Figure 1B–G). Amot ablation clearly impaired dendritic tree morphological complexity but not the distribution of synaptic markers within the molecular layer, including vesicular gamma-aminobutyric acid transporter (VGAT), vesicular glutamate transporter 1 (VGLUT1) and VGLUT2 (Figure 1H-M). These findings indicate that Amot knockdown in cultured hippocampal neurons did not affect the number of synapses.

Amot deletion in neurons impairs dendritic tree morphology of Purkinje cells.Figure 1. Amot deletion in neurons impairs dendritic tree morphology of Purkinje cells. (Rojek K O, et al., 2019)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Excellent Customer Support

One of the highlights of purchasing AAV8-Syn-Cre was the exceptional customer support. The team was responsive and knowledgeable, assisting us with optimizing our protocols and answering queries promptly. Their support undoubtedly contributed to the smooth execution of our experiments.

United States

10/12/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction